MRNA - IN WAVE B CORRECTION PHASE - OVERALL BEARISH
MRNA, is currently undergoing correction phase. To be specific, the prices are forming counterwaves ABC of smaller degree (red labelling of ABC) as part of higher degree of Wave B (black labelling) formation.
It is predicted the higher degree of Wave B will end at around USD163 before making bigger downtrend movement of Wave C. The target for Wave C is to hit minimal of around USD79 (61.8% FIBO correction), or to the worst of around USD49.6 (78.6% FIBO correction).
A stock of potential shorting opportunities on rebound.
Happy trading.
It is predicted the higher degree of Wave B will end at around USD163 before making bigger downtrend movement of Wave C. The target for Wave C is to hit minimal of around USD79 (61.8% FIBO correction), or to the worst of around USD49.6 (78.6% FIBO correction).
A stock of potential shorting opportunities on rebound.
Happy trading.